布林西多福维尔是一种强大的复制抑制剂,可以对抗非洲猪瘟病毒
相关实验视频
Updated: Jul 28, 2025

05:59
Nasal Wipes for Influenza A Virus Detection and Isolation from Swine
Published on: December 4, 2015
9.5K
Shibang Guo1,2, Yibo Zhang1,2, Zhankui Liu1,2
1National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, People's Republic of China.
Emerging microbes & infections
|June 5, 2023
概括
布林西多福维尔在对抗非洲猪瘟病毒 (ASFV) 感染方面表现有前途. 这种抗病毒剂显著减少了ASFV的复制,并保护猪免受致命的结果,为疾病控制提供了潜在的新策略.
科学领域:
- 兽医病毒学 兽医病毒学
- 传染性疾病 传染性疾病
- 药物发现 药物发现 药物发现
背景情况:
- 非洲猪瘟病毒 (ASFV) 对全球猪业构成重大威胁,目前没有安全有效的疫苗或治疗方法.
- 由于缺乏有效的对策,迫切需要开发针对ASFV的新型抗病毒策略.
研究的目的:
- 使用激酶抑制剂库识别安全有效的抗病毒化合物,对抗非洲猪瘟病毒 (ASFV).
- 评估已识别的化合物在体外和体内用于预防和控制ASFV感染的疗效.
主要方法:
- 使用感染ASFV的初级猪膜巨细胞对酶抑制剂库的查.
- 在体外测试以确定候选化合物的抑制度 (IC50) 和细胞毒性 (CC50).
- 在体内猪挑战实验中评估保护效果,病毒载量减少和本病理变化.
主要成果:
- 六种化合物抑制ASFV感染超过90%,其中布林西多福维尔显示最佳疗效 (IC50 = 2.76nM,CC50 = 58μM).
- 布林西多福维尔以剂量依赖的方式降低了ASFV复制,病毒标位和结构蛋白表达,干扰了入侵后的阶段.
- 在体内,布林西多福维尔保护猪免受ASFV致命性,减少病毒载量和流失,并减轻相关组织损伤.
结论:
- 布林西多福维尔显示出作为预防和控制非洲猪瘟病毒 (ASFV) 感染的有效药物的巨大潜力.
- 进一步的研究是有必要的,以充分探索布林西多福维尔的治疗应用在ASFV.
相关概念视频
Subviral Agents
48
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
48
RNA Interference
26.1K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K
Retroviruses
12.5K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.5K
Viruses with RNA Genomes
60
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
60

